AJMC October 21, 2024
Pearl Steinzor

Key Takeaways

  • Specialty pharmaceutical pipeline discussions focused on novel treatments and the complexities of drug coverage policies.
  • Vertical integration of PBMs and insurers creates inconsistencies in specialty drug access, complicating patient navigation.
  • Biosimilar adoption faces challenges like reimbursement structures and requires innovative strategies to enhance uptake and reduce costs.
  • The 2024 presidential election could significantly impact health policy, with potential shifts in the ACA, drug pricing, and telehealth regulations.

The AMCP Nexus 2024 annual meeting covered a variety of hot health care topics impacting managed care pharmacy in the present and future.

The AMCP Nexus 2024 annual meeting took place between October 14 and October 17, 2024, in Las Vegas, Nevada. The conference featured over 30 education sessions...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Pharma, Pharma / Biotech, Trends
Gene Therapy for Cardiomyopathies Presents Promising Alternative to Current Treatment
STAT+: 3 trends to watch in biotech in 2025
CVS, Walgreens & Walmart's healthcare strategy faces headwinds: 10 notes from 2024
The GLP-1 dilemma persists into 2025
The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender

Share This Article